COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

Senger, Mario Roberto; Evangelista, Tereza Cristina Santos; Dantas, Rafael Ferreira; Santana, Marcos Vinicius da Silva; Gonçalves, Luiz Carlos Saramago; Souza Neto, Lauro Ribeiro de; Ferreira, Sabrina Baptista; Silva Junior, Floriano Paes.
Artículo en Inglés | ARCA | ID: arc-43817

Documentos relacionados

  1. [Drug treatment of coronavirus disease COVID-19: evidence exists?]
  2. [Psychiatric symptoms and COVID-19: results of a national case register].
  3. [Social Inequalities and COVID-19: Social-Epidemiological Perspectives on the Pandemic].
  4. [Chemosensory disorders in Covid-19: Pathomechanisms and clinical relevance].
  5. Ocular Involvement in COVID-19: Conjunctivitis and More.
  6. [Sports activity and COVID-19: what's new?]
  7. COVID-19: Ophthalmological Aspects of the SARS-CoV 2 Global Pandemic.
  8. [Clozapine treatment and COVID-19: continue despite leukocytopenia and increase of clozapine serum levels].
  9. [Epilepsy and COVID-19: patient management and optimization of antiepileptic therapy during pandemic].
  10. [Vitamin D and COVID-19: a communication far from reality].